NVAX CIK: 1000694

Novavax Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.32
FY22:
−0.42
FY23:
−0.71
FY24:
−0.09
FY25:
−0.24
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
−0.09
FY23:
−0.06
FY24:
−0.20
FY25:
−0.08
Change from FY21 to FY25
billions USD
FY21:
0.46
FY22:
0.32
FY23:
0.00
FY24:
0.26
FY25:
0.03
billions USD
FY21:
0.88
FY22:
−0.18
FY23:
−0.77
FY24:
−0.04
FY25:
−0.29
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.27
FY22:
−0.50
FY23:
−0.77
FY24:
−0.10
FY25:
−0.25

All amounts in billions USD Data source:SEC EDGAR